An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes

Leishmania donovani N1 N2 neutrophil heterogeneity neutrophils polarization tumor-associated neutrophils visceral leishmaniasis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 06 12 2019
accepted: 09 03 2020
entrez: 16 5 2020
pubmed: 16 5 2020
medline: 27 3 2021
Statut: epublish

Résumé

Neutrophils act as the first line of defense against invading pathogens. Although traditionally considered in context of their antimicrobial effector functions, the importance of tumor-associated neutrophils (TANs) in the development of cancer has become increasingly clear during the last decade. With regard to their high plasticity, neutrophils were shown to acquire an anti-tumorigenic N1 or a pro-tumorigenic N2 phenotype. Despite the urgent need to get a comprehensive understanding of the interaction of TANs with their tumor microenvironment, most studies still rely on murine tumor models. Here we present for the first time a polarization attempt to generate N1 and N2 neutrophils from primary human neutrophils

Identifiants

pubmed: 32411122
doi: 10.3389/fimmu.2020.00532
pmc: PMC7198726
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

532

Informations de copyright

Copyright © 2020 Ohms, Möller and Laskay.

Références

J Clin Oncol. 2005 Apr 20;23(12):2840-55
pubmed: 15837998
Trends Parasitol. 2009 Nov;25(11):505-10
pubmed: 19762280
Carcinogenesis. 2009 Mar;30(3):377-86
pubmed: 19136477
J Immunol. 2001 Jan 15;166(2):1141-7
pubmed: 11145695
Immunology. 2003 Feb;108(2):177-88
pubmed: 12562326
Cancer Lett. 2007 Feb 8;246(1-2):100-8
pubmed: 16564616
Cancer Cell. 2009 Sep 8;16(3):183-94
pubmed: 19732719
J Immunol. 2004 Dec 1;173(11):6521-5
pubmed: 15557140
J Immunol. 1997 Feb 1;158(3):1246-53
pubmed: 9013966
Nat Rev Cancer. 2016 Jul;16(7):431-46
pubmed: 27282249
Int J Cancer. 2015 Feb 1;136(3):572-83
pubmed: 24806531
Immunol Rev. 2016 Sep;273(1):312-28
pubmed: 27558343
J Immunol. 2008 Mar 15;180(6):4090-7
pubmed: 18322219
World J Surg. 2009 Jul;33(7):1439-45
pubmed: 19440651
Br Med Bull. 2018 Dec 1;128(1):5-14
pubmed: 30137312
Vaccines (Basel). 2016 Jun 24;4(3):
pubmed: 27348007
Am J Pathol. 2004 Dec;165(6):1853-63
pubmed: 15579430
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6748-53
pubmed: 19346483
Ann Allergy Asthma Immunol. 2014 Dec;113(6):635-640.e2
pubmed: 25256681
PLoS Pathog. 2012;8(4):e1002658
pubmed: 22577359
Arthritis Rheum. 1986 Nov;29(11):1334-42
pubmed: 2430586
Immunology. 2004 May;112(1):2-12
pubmed: 15096178
Cancer Gene Ther. 2002 May;9(5):432-42
pubmed: 11961666
Int J Cancer. 2016 Apr 15;138(8):1982-93
pubmed: 26619320
Apoptosis. 2003 Aug;8(4):345-52
pubmed: 12815277
Cancer Cell. 2009 Sep 8;16(3):173-4
pubmed: 19732714
Int J Mol Sci. 2019 Jan 27;20(3):
pubmed: 30691207
J Natl Cancer Inst. 1984 Aug;73(2):331-9
pubmed: 6205210
Cytokine. 2018 Sep;109:24-28
pubmed: 29449068
Cancer Res. 2001 Jun 15;61(12):4756-60
pubmed: 11406548
J Immunother Cancer. 2018 Jun 18;6(1):57
pubmed: 29914571
Front Physiol. 2018 Feb 20;9:113
pubmed: 29515456
Cancer Immunol Res. 2016 Nov;4(11):968-982
pubmed: 27737879
Gut. 2018 Jun;67(6):1112-1123
pubmed: 29196437
Am J Trop Med Hyg. 2017 Sep;97(3):767-770
pubmed: 28820688
Cancer Gene Ther. 2009 Feb;16(2):149-60
pubmed: 18670452
J Immunol. 1998 Dec 1;161(11):6148-55
pubmed: 9834100
Front Immunol. 2016 Feb 16;7:52
pubmed: 26909082
PLoS One. 2012;7(6):e38489
pubmed: 22701652
J Immunol. 2011 Jul 1;187(1):490-500
pubmed: 21606249
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):E566-75
pubmed: 25624500
J Invest Dermatol. 2014 Sep;134(9):2339-2346
pubmed: 24583949
Trends Microbiol. 2003 May;11(5):210-4
pubmed: 12781523
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
PLoS One. 2012;7(11):e48939
pubmed: 23152825
Cell Rep. 2015 Dec 29;13(12):2829-2841
pubmed: 26711347
Carcinogenesis. 2012 May;33(5):949-55
pubmed: 22425643
Gynecol Oncol. 2000 Sep;78(3 Pt 1):383-7
pubmed: 10985899
Braz J Med Biol Res. 2010 Sep;43(9):853-8
pubmed: 20721471
Urology. 2007 Jun;69(6):1210-5
pubmed: 17572226
Surg Today. 1992;22(4):322-7
pubmed: 1392343
Biochem Biophys Res Commun. 1995 May 5;210(1):51-7
pubmed: 7537965
Intern Med. 2009;48(9):687-91
pubmed: 19420814
Cardiovasc Res. 2016 May 1;110(1):51-61
pubmed: 26825554
J Immunol. 2003 May 15;170(10):5152-8
pubmed: 12734362
Arthritis Rheumatol. 2015 Jul;67(7):1922-32
pubmed: 25891759
J Immunol. 2002 Jul 15;169(2):898-905
pubmed: 12097394
Blood. 1991 Jun 15;77(12):2553-5
pubmed: 2043760
Oncoimmunology. 2016 Sep 13;5(11):e1232221
pubmed: 27999744
Infect Immun. 2013 Nov;81(11):3966-74
pubmed: 23918780
Mol Cancer Ther. 2013 May;12(5):799-808
pubmed: 23468530

Auteurs

Mareike Ohms (M)

Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.

Sonja Möller (S)

Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.

Tamás Laskay (T)

Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH